BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Comas-Garcia M, Colunga-Saucedo M, Rosales-Mendoza S. The Role of Virus-Like Particles in Medical Biotechnology. Mol Pharm 2020;17:4407-20. [PMID: 33147978 DOI: 10.1021/acs.molpharmaceut.0c00828] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Yu X, Weng Z, Zhao Z, Xu J, Qi Z, Liu J. Assembly of Protein Cages for Drug Delivery. Pharmaceutics 2022;14:2609. [DOI: 10.3390/pharmaceutics14122609] [Reference Citation Analysis]
2 De Sá Magalhães S, De Santis E, Hussein-gore S, Colomb-delsuc M, Keshavarz-moore E. Quality assessment of virus-like particle: A new transmission electron microscopy approach. Front Mol Biosci 2022;9. [DOI: 10.3389/fmolb.2022.975054] [Reference Citation Analysis]
3 Kwon S, Giessen TW. Engineered Protein Nanocages for Concurrent RNA and Protein Packaging In Vivo. ACS Synth Biol 2022. [PMID: 36170610 DOI: 10.1021/acssynbio.2c00391] [Reference Citation Analysis]
4 Wang L, Shi Y, Jiang J, Li C, Zhang H, Zhang X, Jiang T, Wang L, Wang Y, Feng L. Micro‐Nanocarriers Based Drug Delivery Technology for Blood‐Brain Barrier Crossing and Brain Tumor Targeting Therapy. Small. [DOI: 10.1002/smll.202203678] [Reference Citation Analysis]
5 Kwon S, Giessen TW. Engineered protein nanocages for concurrent RNA and protein packaging in vivo.. [DOI: 10.1101/2022.06.16.496435] [Reference Citation Analysis]
6 Saxena P. Nano-Biomaterials for Immunotherapy Applications. Bionanotechnology: Next-Generation Therapeutic Tools 2022. [DOI: 10.2174/9789815051278122010004] [Reference Citation Analysis]
7 Deshayes C, Gosselin-Grenet AS, Ogliastro M, Lapied B, Apaire-Marchais V. Can Virus-like Particles Be Used as Synergistic Agent in Pest Management? Viruses 2022;14:943. [PMID: 35632685 DOI: 10.3390/v14050943] [Reference Citation Analysis]
8 Tariq H, Batool S, Asif S, Ali M, Abbasi BH. Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases. Front Microbiol 2021;12:790121. [PMID: 35046918 DOI: 10.3389/fmicb.2021.790121] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
9 García-silva I, Colunga-saucedo M, Almendarez-rodríguez C, Miranda-lópez C, Rosales-mendoza S, Comas-garcia M. Virus-like particle-based vaccines against SARS-CoV-2. Biomedical Innovations to Combat COVID-19 2022. [DOI: 10.1016/b978-0-323-90248-9.00005-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Liu T, Yang Q, Zheng H, Jia H, He Y, Zhang X, Zheng J, Xi Y, Zhang H, Sun R, Chen X, Shan W. Multifaceted roles of a bioengineered nanoreactor in repressing radiation-induced lung injury. Biomaterials 2021;277:121103. [PMID: 34478930 DOI: 10.1016/j.biomaterials.2021.121103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
11 Yang L, Wang Y, Yao C, Xu X. Highly sensitive and portable aptasensor by using enzymatic nanoreactors as labels. Microchemical Journal 2021;168:106407. [DOI: 10.1016/j.microc.2021.106407] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]